Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment
source: Blood
year: 2017
authors: Berthaut I, Bachir D, Kotti S, Chalas C, Stankovic K, Eustache F, Ravel C, Habibi A, Brailly-Tabard S, Lévy-Dutel L, Bleibtreu A, Simon T, Galactéros F, Lionnet F, Mandelbaum J
summary/abstract:The prognosis of sickle cell anemia (SCA), initially disastrous in the severe forms of the disease, has greatly improved, leading to increased life expectancy. More than 95% to 99% of the children diagnosed with SCA in developed countries will become young adults, reaching reproductive age and able to consider having children of their own. Hydroxyurea (HU) is the main therapy that has considerably modified the prognosis of SCA, allowing, with good compliance, a substantial decrease in morbidity and mortality and significant improvement in quality of life.
Only 3 groups, including our own, have reported the potentially detrimental effect of HU on sperm parameters, when initiated in adult patients. These retrospective studies were performed among as few as 8 participants, without any comparative semen assessment before initiation of HU in 7 participants. On the basis of this observation, a prospective multicenter study was designed to assess the effect of 6 months of HU treatment (representing 2 complete cycles of spermatogenesis) on total sperm count (TSC; millions per ejaculate) in 35 men with severe forms of SCA.
organization: Université Paris 06, France; Université Paris 12, France; Université Paris 05, France; Hôpital Tenon, Université Paris 13, France; Centre Hospitalier Universitaire de Rennes, France; Université Paris Sud, France; Université Paris 07, FranceDOI: 10.1182/blood-2017-03-771857
read more full text
Related Content
-
What Should Teens Ask Their Doctors About Hydroxyureahttps://www.youtube.com/watch?v=VZn15uXQ...
-
Hydroxyurea (hydroxycarbamide) for sickle cell diseaseBACKGROUND: Sickle cell disease (SCD) i...
-
Effects of Hydroxyurea Treatment for Patients With Hemoglobin SC DiseaseAlthough hemoglobin SC (HbSC) disease is...
-
Effort set to help sickle cell patients manage medsVanderbilt University Medical Center is ...
-
Teen with sickle cell disease takes class trip to Europe with Loyola Medicine’s helpAnyah Randolph, a teenager with sickle c...
-
MKSAP: 24-Year-Old Woman With Sickle Cell AnemiaA 24-year-old woman undergoes routine ev...
-
Sickle Cell Anemia Toddlers Benefit from Maximal Hydroxyurea Doses, Study FindsIntensifying treatment with hydroxyurea ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.